Heparin-paclitaxel conjugates as drug delivery system: Synthesis, self-assembly property, drug release, and antitumor activity

Bioconjugate Chemistry

Volumn 20, Issue 12, 2009, Pages 2214-2221

  Wang, Ying ^a   Xin, Dingcheng ^a   Liu, Kaijian ^a   Zhu, Mingqiang ^a   Xiang, Jiannan ^a  

^a HUNAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; HYDROPHILICITY; NANOPARTICLES; PHYSIOLOGY; POLYSACCHARIDES; RISK ASSESSMENT; SELF ASSEMBLY; SOLUTIONS; TARGETED DRUG DELIVERY; TUMORS;

AMINO-ACIDS; ANTITUMOUR ACTIVITY; DRUG RELEASE; DRUG-DELIVERY SYSTEMS; MCF-7 CELLS; PACLITAXEL; PHYSIOLOGICAL CONDITION; PRODRUGS; PROPERTY; SYSTEM SYNTHESIS;

AMINO ACIDS;

HEPARIN; LEUCINE; NANOPARTICLE; PACLITAXEL; PHENYLALANINE; PRODRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BLEEDING; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; FLOW CYTOMETRY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROLYSIS; HYDROPHILICITY; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PARTICLE SIZE; PLASMA; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY;

MUS;

EID: 72449141425     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc8003809     Document Type: Article

References (33)

1. Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van-Echo, D. A., Von-Hoff, D. D., and Leyland-Jones, B. (1990) Hypersensitivity reactions from taxol. J. Clin. Oncol. 8, 1263-1268.
2. Deutsch, H. M., Glinski, J. A., Hernandez, M., Haugwitz, R. D., Narayanan, V. L., Suffness, M., and Zalkow, L. H. (1989) Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity. J. Med. Chem. 32, 788-792. (Pubitemid 19100192)
3. Mathew, A. E., Mejillano, M. R., Nath, J. P., Himes, R. H., and Stella, V. J. (1992) Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity. J. Med. Chem. 35, 145-151.
4. Zhao, Z., Kingston, D. G. I., and Crosswell, A. R. (1991) Modified taxols 6. Preparation of water-soluble prodrugs of taxol. J. Nat. Prod. 54, 1607-1611.
5. Ueda, Y., Mikkilineni, A. B., Knipe, J. O., Rose, W. C., Casazza, A. M., and Vyas, D. M. (1993) Novel water soluble phosphate prodrugs of taxol possessing in vivo antitumor activity. Bioorg. Med. Chem. Lett. 3, 1761-1766. (Pubitemid 23270227)
6. Nicolaou, K. C., Riemer, C., Kerr, M. A., Rideout, D. R., and Wrasidlo, W. W. (1993) Design, synthesis and biological activity of protaxols. Nature 364, 464-466. (Pubitemid 23263221)
7. Veronese, F. M., Schiavon, O., Pasut, G., Mendichi, R., Andersson, L., Tsirk, A., Ford, J., Wu, G., Kneller, S., Davies, J., and Duncan, R. (2005) PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Bioconjugate Chem. 16, 775-784. (Pubitemid 41026163)
8. Liang, H., Chen, S., Chen, M, Lee, P., Chen, C., and Sung, H. (2006) Paclitaxel-loaded poly(γ-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells. Bioconjugate Chem. 17, 291-299. (Pubitemid 41759499)
9. Sugahara, S., Kajiki, M., Kuriyama, H., and Kobayashi, T. (2007) Completed regression of xenografted human carcinomas by a paclitaxel- carboxymethyl dextran conjugate (AZ10992). J. Controlled Release 117, 40-50. (Pubitemid 46161869)
10. De-Groot, F. M. H., Albrecht, C., Koekkoek, R., Beusker, P. H., and Scheeren, H. W. (2003) Cascade-release dendrimers" liberate all end groups upon a single triggering event in the dendritic core. Angew. Chem., Int. Ed. 42, 4490-4494.
11. Wang, Y., Xin, D., Liu, K., and Xiang, J. (2009) Heparin-paclitaxel conjugates using mixed anhydride as intermediate: synthesis, influence of polymer structure on drug release, anticoagulant activity and in vitro efficiency. Pharm. Res. 26, 785-793.
12. Shuai, X., Merdan, T., Schaper, A. K., Xi, F., and Kissel, T. (2004) Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconjugate Chem. 15, 441-448. (Pubitemid 38657848)
13. Li, S., Byrne, B., Welsh, J., and Palmer, A. F. (2007) Self-assembled poly(butadiene)-b-poly(ethylene oxide) polymersomes as paclitaxel carriers. Biotechnol. Prog. 23, 278-285. (Pubitemid 46293515)
14. Lim, H. J., Nam, H. Y., Lee, B. H., Kim, D. J., Ko, J. Y., and Park, J. (2007) A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts. Biotechnol. Prog. 23, 693-697.
15. You, J., Hu, F., Du, Y., and Yuan, H. (2007) Polymeric micelles with glycolipid-like structure and multiple hydrophobic domains for mediating molecular target delivery of paclitaxel. Biomacromolecules 8, 2450-2456. (Pubitemid 47316985)
16. Sahoo, S. K., and Labhasetwar, V. (2005) Enhanced antiproliferative activity of transferring-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharmacol. 5, 373-383.
17. Lee, Y., Park, S., Mok, H., and Park, T. G. (2008) Synthesis, characterization, antitumor activity of pluronic mimicking co-polymer micelles conjugated with doxorubicin via acid-cleavable linkage. Bioconjugate Chem. 19, 525-531. (Pubitemid 351294925)
18. Litzinger, D. C., Buiting, A. M., Rooijen, N., and Huang, L. (1994) Effect of liposomes size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochem. Biophys. Acta. 1190, 99-107. (Pubitemid 24066264)
19. Robert, J. L. (2003) Heparin: structure and activity. J. Med. Chem. 46, 2551-2563.
20. Casu, B., Guerrini, M., Guglieri, S., Naggi, A., Perez, M., Torri, G., Cassinelli, G., Ribatti, D., Carminati, P., Giannini, G., Penco, S., Pisano, C., Belleri, M., Rusnati, M., and Presta, M. (2004) Undersulfated and glycol-split heparins endowed with antiangiogenic activity. J. Med. Chem. 47, 838-848. (Pubitemid 38176787)
21. Lapierre, F., Holme, K., Lam, L., Tressler, R. J., Storm, N., Wee, J., Stack, R. J., Castellot, J., and Tyrrell, D. J. (1996) Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. Glycobiology 6, 355-366. (Pubitemid 26160105)
22. Ito, S., Nakanishi, H., Hirai, T., Kato, T., Kodera, Y., Feng, Z., Kasai, Y., Ito, K., Akiyama, S., Nakao, A., and Tatematsu, M. (2002) Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a lightcycler. Cancer Lett. 183, 195-203. (Pubitemid 34628424)
23. Win, K. Y., and Feng, S. (2006) In Vitro and in Vivo studies on vitamin E TPGS-emulsified poly(D, L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials 27, 2285-2291.
24. Li, C., Yu, D., Newman, R. A., Cabral, F., Stephens, L. C., Hunter, N., Milas, L., and Wallace, S. (1998) Complete regression of well-established tumors using a novel water-soluble poly(l-Glutamic acid)-paclitaxel conjugate. Cancer Res. 58, 2404-2409. (Pubitemid 28252701)
25. Wang, Y., Xin, D., Hu, J., Liu, K., and Xiang, J. (2009) Synthesis and characterization of ternary heparin conjugates by direct covalent bond strategy. Bioorg. Med. Chem. Lett. 19, 149-152.
26. Hashida, M., Takemura, S., Nishikawa, M., and Takakura, Y. (1998) Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine). J. Controlled Release 53, 301-310. (Pubitemid 28218713)
27. Maeda, H., Sawa, T., and Konno, T. (2001) Mechanism of tumor-targeted delivery of macromolecular drugs, including EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Controlled Release 74, 47-61. (Pubitemid 32727608)
28. Masquelier, M., Baurain, R., and Trouet, A. (1980) Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion. J. Med. Chem. 23, 1166-1170. (Pubitemid 11163825)
29. Casu, B., and Naggi, A. (2003) Antiangiogenic heparin-derived heparan sulfate mimics. Pure Appl. Chem. 75, 157-166.
30. Ono, K., Ishihara, M., Ishikawa, K., Ozeki1, Y., Deguchi, H., Sato, M., Hashimoto, H., Saito, Y., Yura, H., Kurita, A., and Maehara, T. (2002) Periodate-treated, non-anticoagulant heparin-carrying polystyrene (NAC-HCPS) affects angiogenesis and inhibits subcutaneous induced tumour growth and metastasis to the lung. Br. J. Cancer 86, 1803-1812. (Pubitemid 34712927)
31. Yoshitomi, Y., Nakanishi, H., Kusano, Y., Munesue, S., Oguri, K., Tatematsu, M., Yamashina, I., and Okayama, M. (2004) Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity. Cancer Lett. 207, 165-174. (Pubitemid 38457037)
32. Schiff, P. B., and Horwitz, S. B. (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. U.S.A. 77, 1561-1565.
33. Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., and Wilson, L. (1996) Mitotic block induced in Hela cells by low concentrations of paclitaxel (taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56, 816-825. (Pubitemid 26055472)